Plc Glaxosmithkline

Insider Trading: Purchases
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
WVE $8.00 2,791,930 Large Shareholder 16,775,691 2024-09-27 Filing
WVE $5.00 3,300,000 Large Shareholder 13,983,761 2023-12-07 Filing
DBTX $18.00 150,000 Director 1,183,663 2021-02-17 Filing
GNCA $2.25 1,260,504 Large Shareholder 4,626,389 2020-07-24 Filing
PAND $18.00 361,111 Large Shareholder, Director 2,248,304 2020-07-21 Filing
NKTX $18.00 833,333 Large Shareholder, Director 3,150,732 2020-07-14 Filing
TPTX $60.00 83,333 Director 2,253,660 2020-05-21 Filing
PRNB $28.00 357,142 Other 2,982,855 2019-10-18 Filing
TPTX $45.00 177,777 Director 2,170,327 2019-09-10 Filing
MORF $15.00 333,333 Director 2,633,772 2019-07-01 Filing
GNCA $3.50 1,857,142 Large Shareholder 3,365,884 2019-06-24 Filing
BCYC $14.00 385,714 Large Shareholder, Director 1,915,275 2019-05-28 Filing
TPTX $18.00 325,000 Large Shareholder, Director 1,992,550 2019-04-22 Filing
PRNB $17.00 270,000 Large Shareholder 2,625,713 2018-09-18 Filing
LQDA $11.00 148,818 Other 624,422 2018-07-30 Filing
SPRO $12.50 80,000 Large Shareholder 1,934,006 2018-07-17 Filing
TBIO $13.00 269,230 Large Shareholder 3,697,912 2018-07-02 Filing
SPRO $14.00 428,571 Large Shareholder 1,854,006 2017-11-06 Filing
CRSP $14.00 66,500 Large Shareholder 3,220,627 2016-10-24 Filing
TBPH $23,027,965.50 1,301,015 Large Shareholder 9,644,807 2016-03-14 Filing